nodes	percent_of_prediction	percent_of_DWPC	metapath
Tubocurarine—HTR3A—fourth ventricle—malignant glioma	0.251	0.439	CbGeAlD
Tubocurarine—ACHE—telencephalon—malignant glioma	0.0197	0.0345	CbGeAlD
Tubocurarine—HTR3A—brainstem—malignant glioma	0.0196	0.0344	CbGeAlD
Tubocurarine—CHRNB1—medulla oblongata—malignant glioma	0.0178	0.0312	CbGeAlD
Tubocurarine—HTR3A—telencephalon—malignant glioma	0.0174	0.0305	CbGeAlD
Tubocurarine—CHRNB1—midbrain—malignant glioma	0.0163	0.0285	CbGeAlD
Tubocurarine—CHRNB1—spinal cord—malignant glioma	0.0159	0.0278	CbGeAlD
Tubocurarine—ACHE—medulla oblongata—malignant glioma	0.0155	0.0271	CbGeAlD
Tubocurarine—CHRM2—telencephalon—malignant glioma	0.0145	0.0255	CbGeAlD
Tubocurarine—SLC22A1—telencephalon—malignant glioma	0.0143	0.025	CbGeAlD
Tubocurarine—ACHE—midbrain—malignant glioma	0.0141	0.0247	CbGeAlD
Tubocurarine—CHRNA2—central nervous system—malignant glioma	0.0139	0.0243	CbGeAlD
Tubocurarine—ACHE—spinal cord—malignant glioma	0.0138	0.0241	CbGeAlD
Tubocurarine—CHRNA2—cerebellum—malignant glioma	0.0135	0.0237	CbGeAlD
Tubocurarine—CHRNA1—brain—malignant glioma	0.0133	0.0232	CbGeAlD
Tubocurarine—CHRNB1—cerebellum—malignant glioma	0.0126	0.0221	CbGeAlD
Tubocurarine—CHRNA2—brain—malignant glioma	0.011	0.0193	CbGeAlD
Tubocurarine—ACHE—cerebellum—malignant glioma	0.0109	0.0191	CbGeAlD
Tubocurarine—CHRNB1—brain—malignant glioma	0.0102	0.0179	CbGeAlD
Tubocurarine—HTR3A—central nervous system—malignant glioma	0.0099	0.0173	CbGeAlD
Tubocurarine—ACHE—brain—malignant glioma	0.00888	0.0155	CbGeAlD
Tubocurarine—CHRM2—central nervous system—malignant glioma	0.00827	0.0145	CbGeAlD
Tubocurarine—SLC22A1—central nervous system—malignant glioma	0.00812	0.0142	CbGeAlD
Tubocurarine—HTR3A—brain—malignant glioma	0.00786	0.0138	CbGeAlD
Tubocurarine—CHRM2—brain—malignant glioma	0.00656	0.0115	CbGeAlD
Tubocurarine—SLC22A1—brain—malignant glioma	0.00645	0.0113	CbGeAlD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000559	0.0013	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000549	0.00128	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000541	0.00126	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—ASMT—malignant glioma	0.000541	0.00126	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000539	0.00126	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	0.000535	0.00125	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LATS2—malignant glioma	0.000535	0.00125	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000533	0.00124	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000528	0.00123	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000522	0.00122	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000522	0.00122	CbGpPWpGaD
Tubocurarine—ACHE—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00052	0.00121	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—BCAN—malignant glioma	0.000508	0.00118	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000508	0.00118	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—COX8A—malignant glioma	0.000507	0.00118	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.0005	0.00117	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000496	0.00116	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000484	0.00113	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000479	0.00112	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—BRAF—malignant glioma	0.000477	0.00111	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—COX8A—malignant glioma	0.000472	0.0011	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCR3—malignant glioma	0.000465	0.00108	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000462	0.00108	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—BCHE—malignant glioma	0.000457	0.00106	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000455	0.00106	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—FBXW7—malignant glioma	0.000449	0.00105	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.000447	0.00104	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.000436	0.00102	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—ASMT—malignant glioma	0.000431	0.001	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000431	0.001	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—BDKRB2—malignant glioma	0.000425	0.000992	CbGpPWpGaD
Tubocurarine—ACHE—Phospholipid metabolism—PIK3CA—malignant glioma	0.000416	0.00097	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000416	0.000968	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000414	0.000965	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000411	0.000958	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—IDH2—malignant glioma	0.00041	0.000955	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—LATS1—malignant glioma	0.000405	0.000944	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—BCAN—malignant glioma	0.000405	0.000944	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000404	0.000942	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—ASMT—malignant glioma	0.000401	0.000936	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000401	0.000935	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—MDM2—malignant glioma	0.0004	0.000931	CbGpPWpGaD
Tubocurarine—ACHE—Neuronal System—RAF1—malignant glioma	0.000398	0.000928	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000395	0.000922	CbGpPWpGaD
Tubocurarine—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000394	0.000919	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000388	0.000903	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000387	0.000903	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—KNG1—malignant glioma	0.000387	0.000902	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000387	0.000901	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000386	0.0009	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000386	0.0009	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2B6—malignant glioma	0.000385	0.000898	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—BRAF—malignant glioma	0.00038	0.000886	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000378	0.000881	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—BCAN—malignant glioma	0.000377	0.00088	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000376	0.000877	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00037	0.000862	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000369	0.000859	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—BRAF—malignant glioma	0.000354	0.000825	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CCR4—malignant glioma	0.000354	0.000824	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—IDH1—malignant glioma	0.000352	0.000821	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000352	0.000821	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000351	0.000818	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000349	0.000814	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SPHK1—malignant glioma	0.000341	0.000795	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CYP2C18—malignant glioma	0.000334	0.000778	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000329	0.000766	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000328	0.000765	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—IDH2—malignant glioma	0.000326	0.000761	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CCR4—malignant glioma	0.000321	0.000749	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000321	0.000748	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—MDM2—malignant glioma	0.000318	0.000742	CbGpPWpGaD
Tubocurarine—SLC22A2—Neuronal System—RAF1—malignant glioma	0.000317	0.000739	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000315	0.000734	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00031	0.000724	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2B6—malignant glioma	0.000307	0.000715	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	0.000306	0.000714	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—IDH2—malignant glioma	0.000304	0.000709	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—MDM2—malignant glioma	0.000297	0.000692	CbGpPWpGaD
Tubocurarine—SLC22A1—Neuronal System—RAF1—malignant glioma	0.000296	0.000689	CbGpPWpGaD
Tubocurarine—CHRM2—G alpha (i) signalling events—CXCL8—malignant glioma	0.000291	0.000679	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	0.000289	0.000675	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000287	0.000669	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2B6—malignant glioma	0.000286	0.000667	CbGpPWpGaD
Tubocurarine—CHRM2—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000281	0.000656	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—IDH1—malignant glioma	0.000281	0.000654	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000277	0.000645	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MDK—malignant glioma	0.000274	0.000638	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SPHK1—malignant glioma	0.000272	0.000633	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTT1—malignant glioma	0.00027	0.00063	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CYP2C18—malignant glioma	0.000266	0.00062	CbGpPWpGaD
Tubocurarine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	0.000266	0.00062	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCR3—malignant glioma	0.000263	0.000613	CbGpPWpGaD
Tubocurarine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000262	0.000611	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—IDH1—malignant glioma	0.000262	0.00061	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DTX1—malignant glioma	0.000261	0.000609	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—F2—malignant glioma	0.000259	0.000604	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SPHK1—malignant glioma	0.000253	0.00059	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS1—malignant glioma	0.000253	0.00059	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000252	0.000588	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—F2—malignant glioma	0.00025	0.000583	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CYP2C18—malignant glioma	0.000248	0.000578	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—BDKRB2—malignant glioma	0.00024	0.00056	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCR3—malignant glioma	0.000239	0.000556	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—BCHE—malignant glioma	0.000235	0.000548	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—SLC5A5—malignant glioma	0.000232	0.000542	CbGpPWpGaD
Tubocurarine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000231	0.00054	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00022	0.000512	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—MMP2—malignant glioma	0.00022	0.000512	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—KNG1—malignant glioma	0.000219	0.00051	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—BDKRB2—malignant glioma	0.000218	0.000509	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000218	0.000508	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTT1—malignant glioma	0.000215	0.000502	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SUFU—malignant glioma	0.000207	0.000483	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HEY2—malignant glioma	0.000205	0.000478	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS1—malignant glioma	0.000202	0.00047	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTT1—malignant glioma	0.000201	0.000468	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—GFAP—malignant glioma	0.0002	0.000466	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KNG1—malignant glioma	0.000199	0.000463	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SPHK1—malignant glioma	0.000194	0.000451	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.00019	0.000443	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HEY1—malignant glioma	0.00019	0.000442	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CCR4—malignant glioma	0.00019	0.000442	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS1—malignant glioma	0.000188	0.000438	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—BCHE—malignant glioma	0.000188	0.000437	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—GSTP1—malignant glioma	0.000187	0.000436	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—SLC5A5—malignant glioma	0.000185	0.000432	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIST1H3B—malignant glioma	0.000184	0.00043	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	0.000183	0.000425	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CAT—malignant glioma	0.000182	0.000425	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR ligand binding—CXCL8—malignant glioma	0.000176	0.000411	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—MMP3—malignant glioma	0.000176	0.00041	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—BCHE—malignant glioma	0.000175	0.000407	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—SLC5A5—malignant glioma	0.000173	0.000402	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—NCOR1—malignant glioma	0.000172	0.000401	CbGpPWpGaD
Tubocurarine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000171	0.000398	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JAG2—malignant glioma	0.000168	0.000392	CbGpPWpGaD
Tubocurarine—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000159	0.000371	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—GSTP1—malignant glioma	0.000149	0.000348	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CAT—malignant glioma	0.000145	0.000338	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—H3F3A—malignant glioma	0.000142	0.000332	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—F2—malignant glioma	0.000141	0.000329	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCR3—malignant glioma	0.000141	0.000329	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—CAV1—malignant glioma	0.00014	0.000327	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—GSTP1—malignant glioma	0.000139	0.000324	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—YWHAE—malignant glioma	0.000137	0.00032	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NTRK2—malignant glioma	0.000137	0.00032	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—NCOR1—malignant glioma	0.000137	0.00032	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FLT1—malignant glioma	0.000137	0.000318	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—DUSP6—malignant glioma	0.000136	0.000317	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CAT—malignant glioma	0.000135	0.000315	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000135	0.000315	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—JAG1—malignant glioma	0.000134	0.000313	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000134	0.000312	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH3—malignant glioma	0.000134	0.000312	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FBXW7—malignant glioma	0.000132	0.000307	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	0.000129	0.000301	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—F2—malignant glioma	0.000128	0.000299	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—NCOR1—malignant glioma	0.000128	0.000298	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CG—malignant glioma	0.000128	0.000298	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	0.000124	0.000288	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PPARG—malignant glioma	0.000123	0.000287	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	0.000123	0.000286	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	0.000121	0.000281	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	0.00012	0.000279	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000119	0.000277	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KNG1—malignant glioma	0.000117	0.000273	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT2—malignant glioma	0.000112	0.000262	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CD—malignant glioma	0.000112	0.000262	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NTRK1—malignant glioma	0.000112	0.000261	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—CAV1—malignant glioma	0.000112	0.00026	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	0.000108	0.000252	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—CAV1—malignant glioma	0.000104	0.000243	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP3—malignant glioma	0.000104	0.000242	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000104	0.000242	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	0.000103	0.00024	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CG—malignant glioma	0.000102	0.000237	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTK2—malignant glioma	0.0001	0.000233	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	9.96e-05	0.000232	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HES1—malignant glioma	9.83e-05	0.000229	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PPARG—malignant glioma	9.83e-05	0.000229	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CB—malignant glioma	9.79e-05	0.000228	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	9.77e-05	0.000228	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTGS2—malignant glioma	9.7e-05	0.000226	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	9.64e-05	0.000225	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	9.52e-05	0.000222	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CG—malignant glioma	9.49e-05	0.000221	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	9.41e-05	0.000219	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	9.36e-05	0.000218	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PPARG—malignant glioma	9.16e-05	0.000213	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—SPP1—malignant glioma	9.09e-05	0.000212	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	9.05e-05	0.000211	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CD—malignant glioma	8.95e-05	0.000209	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—IL2—malignant glioma	8.65e-05	0.000202	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TERT—malignant glioma	8.61e-05	0.000201	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PTEN—malignant glioma	8.46e-05	0.000197	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	8.41e-05	0.000196	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	8.36e-05	0.000195	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CD—malignant glioma	8.34e-05	0.000194	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	8.24e-05	0.000192	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.97e-05	0.000186	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KDR—malignant glioma	7.88e-05	0.000184	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CB—malignant glioma	7.8e-05	0.000182	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTGS2—malignant glioma	7.73e-05	0.00018	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—F2—malignant glioma	7.58e-05	0.000177	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FN1—malignant glioma	7.58e-05	0.000177	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BAD—malignant glioma	7.49e-05	0.000175	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	7.42e-05	0.000173	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CD80—malignant glioma	7.27e-05	0.000169	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CB—malignant glioma	7.27e-05	0.000169	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—APC—malignant glioma	7.26e-05	0.000169	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	7.26e-05	0.000169	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTGS2—malignant glioma	7.2e-05	0.000168	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGF—malignant glioma	7.17e-05	0.000167	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	7.13e-05	0.000166	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.82e-05	0.000159	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PTEN—malignant glioma	6.74e-05	0.000157	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.64e-05	0.000155	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.61e-05	0.000154	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	6.38e-05	0.000149	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	6.32e-05	0.000147	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PTEN—malignant glioma	6.28e-05	0.000146	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	6.25e-05	0.000146	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—FGF2—malignant glioma	6.11e-05	0.000142	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—PIK3CA—malignant glioma	5.97e-05	0.000139	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.74e-05	0.000134	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.72e-05	0.000133	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.7e-05	0.000133	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.64e-05	0.000131	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.56e-05	0.00013	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	5.34e-05	0.000125	CbGpPWpGaD
Tubocurarine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	5.16e-05	0.00012	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—CASP3—malignant glioma	5.11e-05	0.000119	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—IL2—malignant glioma	5.11e-05	0.000119	CbGpPWpGaD
Tubocurarine—ACHE—Metabolism—AKT1—malignant glioma	4.88e-05	0.000114	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.83e-05	0.000113	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.81e-05	0.000112	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—PIK3CA—malignant glioma	4.76e-05	0.000111	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.69e-05	0.000109	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—PIK3CA—malignant glioma	4.43e-05	0.000103	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	4.34e-05	0.000101	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—STAT3—malignant glioma	4.3e-05	0.0001	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—MYC—malignant glioma	3.99e-05	9.31e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.91e-05	9.1e-05	CbGpPWpGaD
Tubocurarine—SLC22A2—Metabolism—AKT1—malignant glioma	3.88e-05	9.05e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.69e-05	8.6e-05	CbGpPWpGaD
Tubocurarine—SLC22A1—Metabolism—AKT1—malignant glioma	3.62e-05	8.44e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.39e-05	7.9e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—TP53—malignant glioma	3.28e-05	7.64e-05	CbGpPWpGaD
Tubocurarine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.77e-05	6.45e-05	CbGpPWpGaD
